Article
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Clinical and experimental dermatology - 1 Dec 2009
Natkunarajah J, Atherton D, Elmslie F, Mansour S, Mortimer P
Abstract excerpt
Primary erythermalgia (erythromelalgia) is a rare autosomal dominant condition characterized by intermittent attacks of erythema, increased skin temperature and severe burning pain in the extremities, in a bilateral symmetrical distribution. Mutations in the SCN9A gene, which encodes a voltage-ga...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.